Computer Programs and Systems logo
Computer Programs and Systems CPSI
report update icon

Quarterly report 2026-Q1
added 05-08-2026

Computer Programs and Systems Cash Flow 2025-2008 | CPSI

Brief overview of Computer Programs and Systems's cash flow quality

Cash flow changes are traced through the five latest available reports from 2021 to 2025.

Across five available reports, cash from operations decreased from $47.7 million to $37 million, leaving a weaker cash base.

Operating cash flow was above zero 4 times out of five. Most, but not all, periods generated cash.

Operating cash margin decreased to 10.7% from 17% initially. The quality of receipts deteriorated.

Conclusion

Computer Programs and Systems's cash profile looks stretched: weak operating cash flow limits investment, payouts and debt-servicing capacity.

Annual Cash Flow Computer Programs and Systems

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008

Operating Cash Flow

37 M 31.1 M -522 K 32.4 M 47.7 M 49.1 M 43.6 M 23.9 M 23.6 M 2.1 M 30.9 M 39 M 29 M 32.2 M 33.5 M 19.6 M 8.81 M -

Depreciation & Amortization

1.09 M 1.35 M 1.95 M 2.44 M 2.16 M 1.79 M 1.41 M 1.8 M 2.47 M 3.06 M 3.17 M 3.66 M 3.43 M 3.16 M 2.5 M 1.85 M 1.77 M -

Accounts Payables

19.6 M 15 M 10.1 M 7.04 M 8.08 M 7.72 M 8.8 M 5.67 M 7.62 M 6.84 M 4.59 M 3.99 M 3.21 M 2.98 M 2.47 M 2.62 M - -

Accounts Receivables

55 M 53 M 56.2 M 51.3 M 34.4 M 32.4 M 38.8 M 40.5 M 38.1 M 31.8 M 22.6 M 23.1 M 20.1 M 19.7 M 21.5 M 25.5 M - -

Total Inventories

623 K 767 K 475 K 784 K 855 K 1.08 M 1.43 M 1.5 M 1.42 M 1.7 M 1.49 M 1.43 M 1.59 M 1.68 M 1.84 M 1.78 M - -

All numbers in USD currency

Quarterly Cash Flow Computer Programs and Systems

2026-Q1 2025-Q3 2025-Q2 2025-Q1 2024-Q3 2024-Q2 2024-Q1 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Operating Cash Flow

15.5 M - - 5.76 M - - -2.03 M - - 9.47 M - 30.2 M 19.1 M 11.8 M - 34.5 M 33.1 M 13.7 M - 33 M 24.8 M 7.59 M - 25.5 M - 17.5 M - 14.9 M 7.82 M 3.12 M - 18.3 M 15.9 M 9.69 M - -2.57 M -8.48 M 834 K - 26.3 M 17.4 M 13.6 M - 26.1 M 14.5 M 13.2 M - 14.3 M 6.78 M 5.52 M - 18 M 11.5 M 8.55 M - 24.2 M 17.1 M 14.3 M

Depreciation & Amortization

271 K 243 K 312 K 291 K 279 K 400 K 400 K 297 K 597 K 498 K - 622 K 690 K 578 K - 525 K 563 K 553 K - 1.33 M 892 K 420 K - 1.08 M 2.52 M 730 K - 1.42 M 1.07 M 529 K - 1.94 M 1.42 M 718 K - 2.42 M 1.74 M 852 K - 2.5 M 1.83 M 911 K - 2.73 M 1.86 M 930 K - 2.56 M 1.72 M 850 K - 2.34 M 1.67 M 819 K - 1.77 M 1.23 M 609 K

Accounts Payables

22.5 M 20.2 M 19.7 M 14.9 M 14 M 15.9 M - 13.4 M 14.5 M 12.6 M 7.04 M 7.48 M 8 M 7.24 M 8.08 M 5.45 M 6.85 M 6.74 M 7.72 M 7.72 M 7.72 M 7.72 M 8.8 M 8.8 M 5.42 M 8.8 M 5.67 M 5.67 M 5.67 M 5.67 M 7.62 M 7.62 M 7.62 M 7.62 M 6.84 M 6.84 M 6.84 M 6.84 M 4.59 M 4.59 M 4.59 M 4.59 M 3.99 M 3.99 M 3.99 M 3.99 M 3.21 M 3.21 M 3.21 M 3.21 M 2.98 M 2.98 M 2.98 M 2.98 M 2.47 M 2.47 M 2.47 M 2.47 M

Accounts Receivables

50.9 M 56.8 M 56.4 M 56.6 M 56.7 M 59.6 M - 59 M 54.9 M 54.7 M 51.3 M 45.6 M 48.8 M 41.5 M 34.4 M 30.5 M 30.9 M 33.8 M 32.4 M 32.4 M 32.4 M 32.4 M 38.8 M 38.8 M 37.7 M 38.8 M 40.5 M 40.5 M 40.5 M 40.5 M 38.1 M 38.1 M 38.1 M 38.1 M 31.8 M 31.8 M 31.8 M 31.8 M 22.6 M 22.6 M 22.6 M 22.6 M 23.1 M 23.1 M 23.1 M 23.1 M 20.1 M 20.1 M 20.1 M 20.1 M 19.7 M 19.7 M 19.7 M 19.7 M 21.5 M 21.5 M 21.5 M 21.5 M

Total Inventories

958 K 351 K 444 K 595 K 924 K 793 K - 941 K 962 K 1.18 M 784 K 1.75 M 1.13 M 567 K 855 K 1.15 M 1.42 M 1.34 M 1.08 M 1.08 M 1.08 M 1.08 M 1.43 M 1.43 M 1.87 M 1.43 M 1.5 M 1.5 M 1.5 M 1.5 M 1.42 M 1.42 M 1.42 M 1.42 M 1.7 M 1.7 M 1.7 M 1.7 M 1.5 M 1.5 M 1.5 M 1.5 M 1.43 M 1.43 M 1.43 M 1.43 M 1.59 M 1.59 M 1.59 M 1.59 M 1.68 M 1.68 M 1.68 M 1.68 M 1.84 M 1.84 M 1.84 M 1.84 M

All numbers in USD currency

Cash Flow Statement is one of the three key financial reports of the company Computer Programs and Systems, reflecting the actual cash inflows and outflows over a certain period. Unlike the income statement, which shows revenues and expenses on an accrual basis, the cash flow statement focuses on real cash flows — how much cash actually came into the company and how much was spent.

Main Sections of the Cash Flow Statement
  • Operating Activities
    This section reflects cash flows related to the company’s core operations: receipts from sales of goods and services, payments to suppliers, employee salaries, taxes, and other operating expenses. Positive cash flow from operating activities indicates the viability of the business and its ability to generate cash.
  • Investing Activities
    Shows cash movements related to the purchase and sale of long-term assets such as real estate, equipment, and investments in other companies. Negative cash flow here often indicates investments in growth, which can be a positive sign.
  • Financing Activities
    Reflects the inflow and outflow of cash related to raising and repaying capital: issuing shares, loans, dividend payments, and loan repayments. This section shows how the company finances its activities and distributes profits.

The cash flow statement is important for investors because it allows them to assess the company’s real liquidity, showing whether it has enough cash to cover current obligations and investments — this is critical for financial stability. Additionally, it helps analyze the quality of earnings, since profits reported in the income statement can be "paper" profits and may not reflect actual cash inflows; the cash flow statement reveals this difference. The presence of free cash is also crucial for evaluating the company’s ability to finance growth and pay dividends, which is important for investors. Attention should also be paid to prolonged negative cash flows from operating activities, as this may serve as a warning sign of potential problems with the core business.

Cash flow statements of other stocks in the Health information services sector

Issuer Price % 24h Market Cap Country
Cerner Corporation Cerner Corporation
CERN
- - $ 27.9 B usaUSA
Accolade Accolade
ACCD
- 0.29 % $ 206 M usaUSA
Change Healthcare Change Healthcare
CHNG
- - $ 9.03 B usaUSA
Covetrus Covetrus
CVET
- - $ 2.94 B usaUSA
So-Young International So-Young International
SY
$ 1.84 0.55 % $ 143 M chinaChina
iCAD iCAD
ICAD
- - $ 102 M usaUSA
HealthEquity HealthEquity
HQY
$ 100.61 -0.38 % $ 8.67 B usaUSA
Akerna Corp. Akerna Corp.
KERN
- - $ 161 M usaUSA
Allscripts Healthcare Solutions Allscripts Healthcare Solutions
MDRX
- -10.39 % $ 886 M usaUSA
MTBC MTBC
MTBC
- -0.58 % $ 51.7 M usaUSA
Zhongchao Zhongchao
ZCMD
$ 1.13 -11.72 % $ 3.86 M chinaChina
1Life Healthcare 1Life Healthcare
ONEM
- - $ 3.37 B usaUSA
NextGen Healthcare NextGen Healthcare
NXGN
- - $ 1.6 B usaUSA
Premier Premier
PINC
- - $ 2.33 B usaUSA
American Well Corporation American Well Corporation
AMWL
$ 10.75 -0.83 % $ 173 M usaUSA
R1 RCM R1 RCM
RCM
- - $ 3.81 B usaUSA
Signify Health Signify Health
SGFY
- -0.02 % $ 7.21 B usaUSA
Streamline Health Solutions Streamline Health Solutions
STRM
- - $ 21.4 M usaUSA
NantHealth NantHealth
NH
- -46.64 % $ 10.4 M usaUSA
SCWorx Corp. SCWorx Corp.
WORX
- - $ 7.71 M usaUSA
Tabula Rasa HealthCare Tabula Rasa HealthCare
TRHC
- - $ 255 M usaUSA
OptimizeRx Corporation OptimizeRx Corporation
OPRX
$ 6.05 -3.51 % $ 112 M usaUSA
Progyny Progyny
PGNY
$ 31.13 -1.14 % $ 2.65 B usaUSA
Phreesia Phreesia
PHR
$ 10.73 1.13 % $ 641 M usaUSA
GoodRx Holdings GoodRx Holdings
GDRX
$ 3.07 -3.15 % $ 1.09 B usaUSA
Schrödinger Schrödinger
SDGR
$ 15.14 -1.37 % $ 1.11 B usaUSA
Omnicell Omnicell
OMCL
$ 35.37 -4.69 % $ 1.63 B usaUSA
Health Catalyst Health Catalyst
HCAT
$ 2.09 0.48 % $ 146 M usaUSA
HealthStream HealthStream
HSTM
$ 28.04 -0.57 % $ 842 M usaUSA
Evolent Health Evolent Health
EVH
$ 3.09 -2.83 % $ 353 M usaUSA
Teladoc Health Teladoc Health
TDOC
$ 6.71 2.05 % $ 1.18 B usaUSA
10x Genomics 10x Genomics
TXG
$ 47.27 -4.37 % $ 5.9 B usaUSA
Veeva Systems Veeva Systems
VEEV
$ 203.78 1.1 % $ 33.4 B usaUSA